TABLE 3

Three Distinct ER-Positive Metastatic Breast Cancer Subgroups as Identified by Agglomerative Hierarchical Cluster Analysis of 18F-FES PET/CT

Imaging featuresGroup 1 (n = 26)Group 2 (n = 27)Group 3 (n = 38)P
Number of metastases, overall3.5 (2.0–10.8)33.0 (22.0–55.0)5.5 (3.0–10.8)7.45E−11
Number of metastases, bone2.0 (0.0–7.8)26.0 (19.0–47.5)2.0 (1.0–5.0)1.35E−11
Geometric mean 18F-FES SUVmax1.1 (1.0–1.4)3.4 (2.5–4.7)2.7 (2.3–3.6)7.29E−12
Percentage metastases visible on CT per patient100.0 (94.6–100.0)40.0 (28.2–59.5)55.0 (31.8–96.9)9.96E−09
Percentage metastases positive on 18F-FES PET3.6 (0.0–31.2)100.0 (90.9–100.0)100.0 (91.0–100.0)6.27E−14
Number of metastases visible on CT3.0 (2.0–10.0)14.0 (5.5–24.5)2.5 (1.0–5.0)9.36E−07
Number of metastases positive on 18F-FES PET0.5 (0.0–1.0)28.0 (20.0–54.5)5.5 (2.2–9.0)6.99E−14
  • Imaging features were first assessed on a patient level and then summarized per group as medians, with interquartile ranges in parentheses; P values are based on Kruskal–Wallis rank sum tests.